Short Information | Novo Nordisk A/S (NYSE:NVO)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 418,561 |
Total Actual Volume | 74,205,971 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 20,928 |
Average Short Percentage | 0.53% |
Is there a NVO Short Squeeze or Breakout about to happen?
See the NVO Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-02-2024 | $141.69 | $142.98 | $143.37 | $139.03 | 5,900,099 | 28,039 | 0.48% |
07-01-2024 | $143.59 | $145.42 | $145.99 | $143.56 | 3,435,776 | 21,901 | 0.64% |
06-28-2024 | $144.66 | $142.74 | $145.59 | $142.67 | 2,757,544 | 6,407 | 0.23% |
06-27-2024 | $143.86 | $144.49 | $145.36 | $143.43 | 2,592,441 | 9,900 | 0.38% |
06-26-2024 | $145.56 | $143.67 | $145.6193 | $142.7941 | 4,384,515 | 24,692 | 0.56% |
06-25-2024 | $145.51 | $146.91 | $148.15 | $144.68 | 6,341,691 | 51,457 | 0.81% |
06-24-2024 | $141.87 | $142.28 | $142.66 | $141.51 | 2,992,090 | 17,101 | 0.57% |
06-21-2024 | $141.46 | $141.96 | $142.56 | $141.21 | 3,033,303 | 17,426 | 0.57% |
06-20-2024 | $141.51 | $140.99 | $143.59 | $140.81 | 3,205,591 | 20,811 | 0.65% |
06-18-2024 | $141.06 | $140.8 | $141.71 | $139.78 | 2,640,226 | 6,951 | 0.26% |
06-17-2024 | $142 | $140.37 | $142.13 | $140.34 | 3,164,448 | 11,736 | 0.37% |
06-14-2024 | $142.21 | $142.5 | $143.18 | $141.89 | 2,831,653 | 9,460 | 0.33% |
06-13-2024 | $142.83 | $142.49 | $142.91 | $141.14 | 2,857,184 | 10,318 | 0.36% |
06-12-2024 | $143.52 | $143.26 | $144.5 | $142 | 3,242,786 | 13,695 | 0.42% |
06-11-2024 | $141.91 | $141.79 | $142.94 | $141.02 | 4,433,332 | 28,032 | 0.63% |
06-10-2024 | $142.115 | $143.63 | $143.94 | $141.25 | 3,655,019 | 24,411 | 0.67% |
06-07-2024 | $143.07 | $142.88 | $143.73 | $142.27 | 3,511,197 | 16,794 | 0.48% |
06-06-2024 | $141.19 | $142.4 | $142.94 | $140.8901 | 4,369,174 | 27,904 | 0.64% |
06-05-2024 | $141.36 | $141 | $142.4095 | $140.08 | 3,786,730 | 29,160 | 0.77% |
06-04-2024 | $136.44 | $139.92 | $140 | $135.78 | 5,071,172 | 42,366 | 0.84% |
News, Short Squeeze, Breakout and More Instantly...
2024-07-02 11:54:16 ET Shares of Novo Nordisk (NYSE: NVO) were slipping 1.7% lower as of 10:57 a.m. ET on Tuesday, after falling as much as 4.4% earlier in the day. The decline came after USA Today published an opinion piece in which President Joe Biden and independent Senator B...
2024-06-30 09:15:00 ET Novo Nordisk (NYSE: NVO) has emerged as one of the biggest names in the pharmaceutical world thanks to its robust line of glucagon-like peptide-1 (GLP-1) medicines. The Danish drugmaker develops Ozempic, Rybelsus, Saxenda, and Wegovy. While Ozempic is appr...
2024-06-29 11:34:00 ET For most of its existence, Altimmune (NASDAQ: ALT) has been a little-known biotech aspiring to compete in a world dominated by whales like Novo Nordisk (NYSE: NVO) , the maker of the hit weight loss drug Wegovy and the blockbuster Ozempic for type 2 di...